Amarsons Drugs And Medicines Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 36 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.30 M
About Amarsons Drugs And Medicines
Amarsons Drugs And Medicines Pvt Ltd (ADAMPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 May 1988 and has a history of 36 years and nine months. Its registered office is in Jalandhar, Punjab, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹0.30 M.
Daljeet Singh and Amardeep Singh serve as directors at the Company.
Company Details
-
Location
Jalandhar, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232PB1988PTC008352
-
Company No.
008352
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 May 1988
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Amarsons Drugs And Medicines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daljeet Singh
|
Managing Director | 06-May-1988 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amardeep Singh | Director | 18-Apr-2024 | Current |
Financial Performance of Amarsons Drugs And Medicines.
Amarsons Drugs And Medicines Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amarsons Drugs And Medicines?
In 2017, Amarsons Drugs And Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.30 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Patyla : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 1997 | State Bank Of Patyla | ₹0.30 M | Open |
How Many Employees Work at Amarsons Drugs And Medicines?
Unlock and access historical data on people associated with Amarsons Drugs And Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amarsons Drugs And Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amarsons Drugs And Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
